Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 218

The DOI matches its Crossref record.

Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism

Becattini, Cecilia, Agnelli, Giancarlo, Salvi, Aldo, Grifoni, Stefano, Pancaldi, Leonardo Goffredo, Enea, Iolanda, Balsemin, Franco, Campanini, Mauro, Ghirarduzzi, Angelo, Casazza, Franco·2010·Thrombosis Research
DOI 10.1016/j.thromres.2009.09.017
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.thromres.2009.09.017

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 21

  1. Kasper, 1997, Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism, Heart, 77, 346, 10.1136/hrt.77.4.346 · doi:10.1136/hrt.77.4.346
  2. Goldhaber, 1999, Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry, Lancet, 353, 1386, 10.1016/S0140-6736(98)07534-5 · DOI · Paper page
  3. Grifoni, 2000, Short term clinical outcome of patients with pulmonary embolism, normal blood pressare and echocardiographycal right ventricular dysfunction, Circulation, 101, 2817, 10.1161/01.CIR.101.24.2817 · DOI · Paper page
  4. Kucher, 2005, Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90mm Hg or higher, Arch Intern Med, 165, 1777, 10.1001/archinte.165.15.1777 · DOI · Paper page
  5. Kearon, 2008, Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 133, 454S, 10.1378/chest.08-0658 · DOI · Paper page
  6. Torbicki, 2008, Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology, Eur Heart J, 29, 2276, 10.1093/eurheartj/ehn310 · DOI · Paper page
  7. Konstantinindes, 2002, Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism, N Engl J Med, 347, 1143, 10.1056/NEJMoa021274 · DOI · Paper page
  8. Keyt, 1994, A faster-acting and more form of tissue plasminogen activator, Proc Natl Acad Sci U S A, 91, 3670, 10.1073/pnas.91.9.3670 · doi:10.1073/pnas.91.9.3670
  9. 1999, Single-bolus Tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial, Lancet, 354, 716, 10.1016/S0140-6736(99)07403-6 · DOI · Paper page
  10. 2001, Efficacy and safety of Tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction, Lancet, 358, 605, 10.1016/S0140-6736(01)05775-0 · DOI · Paper page
  11. Sze, 2001, Treatment of massive pulmonary embolus with catheter-directed Tenecteplase, J Vasc Interv Radiol, 12, 12, 10.1016/S1051-0443(07)61710-2 · doi:10.1016/s1051-0443(07)61710-2
  12. Caldicott, 2002, Tenecteplase for massive pulmonary embolus, Resuscitation, 55, 211, 10.1016/S0300-9572(02)00171-5 · doi:10.1016/s0300-9572(02)00171-5
  13. Kline, 2007, Tenecteplase to treat pulmonary embolism in the emergency department, J Thromb Thrombolysis, 23, 101, 10.1007/s11239-006-9018-3 · doi:10.1007/s11239-006-9018-3
  14. Goldhaber, 1993, Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion, Lancet, 341, 507, 10.1016/0140-6736(93)90274-K · DOI · Paper page
  15. Goldhaber, 1986, Acute pulmonary embolism treated with tissue plasminogen activator, Lancet, 2, 886, 10.1016/S0140-6736(86)90411-3 · doi:10.1016/s0140-6736(86)90411-3
  16. Dalla-Volta, 1992, PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen Activator Italian Multicenter Study 2, JACC, 20, 520, 10.1016/0735-1097(92)90002-5 · DOI · Paper page
  17. Meneveau, 2003, In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy, Eur Heart J, 24, 1447, 10.1016/S0195-668X(03)00307-5 · doi:10.1016/s0195-668x(03)00307-5
  18. Binder, 2005, N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism, Circulation, 112, 1573, 10.1161/CIRCULATIONAHA.105.552216 · DOI · Paper page
  19. Kucher, 2003, Incremental prognostic value of troponin I and echocardiography in patients with acute pulmonary embolism, Eur Heart J, 24, 1651, 10.1016/S0195-668X(03)00394-4 · doi:10.1016/s0195-668x(03)00394-4
  20. Janin, 2009, Safety and efficacy of fondaparinux as an adjunctive treatment to thrombolysis in patients with high and intermediate risk pulmonary embolism, J Thromb Thrombolysis, 28, 320, 10.1007/s11239-008-0288-9 · doi:10.1007/s11239-008-0288-9
  21. Konstantinides, 2008, Acute pulmonary embolism, N Engl J Med, 359, 2804, 10.1056/NEJMcp0804570 · DOI · Paper page

Cited by

See all 218

Metadata

Authors
Becattini, C., Agnelli, G., Salvi, A., Grifoni, S., Pancaldi, L. G., Enea, I., Balsemin, F., Campanini, M., Ghirarduzzi, A., & Casazza, F.
Venue
Thrombosis Research
Publisher
Elsevier BV
Published
2010-03
Volume
125
Issue
3
Pages
e82-e86
ISSN
0049-3848 (ISSN-L)
DOI
10.1016/j.thromres.2009.09.017
OpenAlex
W2011351675
Cited by
218
References
0
FWCI
5.75
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. https://app.cochat.ai/papers/10.1016/j.thromres.2009.09.017
The paper
Becattini, C., Agnelli, G., Salvi, A., Grifoni, S., Pancaldi, L. G., Enea, I., Balsemin, F., Campanini, M., Ghirarduzzi, A., & Casazza, F. (2010). Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thrombosis Research. https://doi.org/10.1016/j.thromres.2009.09.017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.